WX

WebserviceX

Agentic AI Equity Research

Coverage blotter·Stock analysis hub·Note 2026-07-01·Latest →

Amazon (AMZN) Stock Analysis

OW

AMZN Equity Research — OVERWEIGHT — July 2026

BKNG →

Rating date

Jul 1, 2026

40 days ago

Desk view

OW

5D move

—

Awaiting market data

Peer rank

68p

Research history

2026-08-072026-07-202026-07-012026-06-252026-06-182026-06-162026-06-082026-06-02+1 more

Investment card · AMZN

Here is the analysis of AMZN as of July 1, 2026.

Desk rating

OW

Tactical OW · 12M OW

Horizon

Short to medium term

Confidence

Medium

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Bias

OVERWEIGHT

Catalysts

  • The multi-month uptrend is under significant stress. While the 200-day SMA ($232.93) still holds, the price is far below the 50-day SMA ($255.56), signaling a broken medium-term trend.
  • Momentum indicators are recovering from oversold extremes — RSI has rebounded from 33.6 to 47.8, and MACD is narrowing from its June trough. Both point to fading selling pressure but not yet a confirmed reversal.
  • The $227–$233 zone is critical support. This area encompasses the June 25 low, the Bollinger lower band (~$227.50), and the 200-day SMA (~$233). A break below would be technically damaging.

Risks

  • Event-driven repricing risk if expectations diverge from incoming evidence.

Market chart

Price context alongside the research narrative.

AMZN Research Note

Full desk note for Jul 1, 2026. Use tabs for catalysts, valuation and risks, or open the full note.

24 min read

WebserviceX · Agentic Research Desk

AMZN Equity Research Note

Published Jul 1, 2026 · Desk view OVERWEIGHT · Generated 2026-07-02T20:23:30Z · Maintained by Walter Vijayakumar · Methodology · Track record

AMZN Stock Rating Summary

AMZN bias

OVERWEIGHT

Horizon

Short to medium term

AMZN key risk

Event-driven repricing risk if expectations diverge from incoming evidence.

AMZN catalyst watch

The multi-month uptrend is under significant stress. While the 200-day SMA ($232.93) still holds, the price is far below the 50-day SMA ($255.56), signaling a broken medium-term trend.

Invalidation

Thesis weakens if catalysts slip or risk markers breach stated levels.

Confidence

Medium

How the call aged · 5D

—Awaiting market dataPeer 68p
Expand

Grading rule: BUY/OVERWEIGHT scores Correct when forward return > 0; UNDERWEIGHT/SELL when < 0; HOLD is Neutral. Window uses 5 US trading sessions after the rating entry close vs benchmark SPY. Scorecard computed 2026-07-02T20:45:12.081946+00:00.

5D move

—

2026-07-01 → awaiting

Outcome

Awaiting market data

5D trend

+3.17%

Vol (20D ann.)

+37.00%

vs SPY: +1.46%

Close 241.7 → — (USD, vendor closes)

Batch scorecard · 2026-07-01 · AMZN

Publish QC

passed
Expand

Pipeline fingerprint 2f45a102687f75c0

Trace 1f2b154d…

No QC issues recorded.